Teneligliptin, Metformin and Dapagliflozin: Uses, Benefits and Key Features

GLIDAPA TENMET is a prescription-only triple fixed-dose combination tablet for adults with type 2 diabetes mellitus. It combines Dapagliflozin 10mg (an SGLT2 inhibitor), Teneligliptin 20mg (a DPP-4 inhibitor) and Metformin Hydrochloride Extended Release (a biguanide) in two strengths: GLIDAPA TENMET 1000 (Metformin 1000mg) and GLIDAPA TENMET 500 (Metformin 500mg). The three medicines lower blood sugar through three different routes, namely the kidneys, the gut hormone (incretin) pathway and the liver and muscle, and are taken together in one tablet to reduce pill burden.

Product Overview

GLIDAPA TENMET is designed for adults with type 2 diabetes who need more than two medicines to reach their HbA1c target. The range has two strengths:

• GLIDAPA TENMET 1000: Dapagliflozin 10mg + Teneligliptin 20mg + Metformin Hydrochloride 1000mg (Extended Release)
• GLIDAPA TENMET 500: Dapagliflozin 10mg + Teneligliptin 20mg + Metformin Hydrochloride 500mg (Extended Release)

Dapagliflozin and teneligliptin stay the same in both strengths. Only the metformin dose changes. Your doctor chooses the strength depending on your blood sugar, kidney function, age, stomach tolerance and other medicines. Always check the strip and carton for the exact strength before use.

The metformin component is an extended release (ER) form. It releases the drug slowly over several hours, which usually improves stomach tolerance compared with plain metformin tablets. Extended release metformin is generally swallowed whole and not crushed or chewed.

Composition and How Each Ingredient Works

1. Dapagliflozin 10 mg (SGLT2 inhibitor)

Dapagliflozin, available in tablets as dapagliflozin propanediol monohydrate, blocks the sodium-glucose co-transporter 2 (SGLT2) in the proximal tubule of the kidney. This transporter normally pulls most of the filtered glucose back into the blood. When it is blocked, the extra glucose leaves the body in the urine. This action does not depend on insulin. Along with the glucose loss, a mild diuretic effect can bring a modest reduction in body weight and blood pressure.

2. Teneligliptin 20 mg (DPP-4 inhibitor)

Teneligliptin blocks the enzyme dipeptidyl peptidase-4 (DPP-4), which normally breaks down incretin hormones such as GLP-1 and GIP. With DPP-4 blocked, incretin levels stay higher for longer. The pancreas then releases more insulin when blood sugar is high and less glucagon. Because the effect depends on the glucose level, the risk of hypoglycaemia is low when it is used without insulin or a sulfonylurea. Teneligliptin has a long half-life of roughly 24 hours, which supports once-daily dosing, and it is cleared by both liver and kidneys.

3. Metformin Hydrochloride Extended Release (500 mg or 1000 mg) (biguanide)

Metformin lowers glucose production by the liver, improves insulin sensitivity in muscle and fat, and slightly reduces glucose absorption in the gut. It is the first-line oral medicine for type 2 diabetes in most national and international guidelines. It does not usually cause hypoglycaemia on its own and is generally weight-neutral.

Why combine them? Each drug works on a different part of the problem. Metformin reduces what the liver produces and improves insulin response, teneligliptin boosts incretin action, and dapagliflozin removes glucose through the kidneys. Because the mechanisms differ, their effects on HbA1c can add up, and none of the three is typically associated with weight gain.

Indications: What Is GLIDAPA TENMET Used For?

GLIDAPA TENMET tablets are used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus when:

• Blood sugar is not adequately controlled on two of the three ingredients together, such as metformin with teneligliptin, or metformin with dapagliflozin
• The patient is already taking all three medicines as separate tablets and the doctor wants to switch to one fixed-dose tablet

This is not a first-line starting treatment. It is not meant for type 1 diabetes or for treating diabetic ketoacidosis.

Teneligliptin 20 mg Uses

• Teneligliptin 20 mg is taken once daily to improve blood sugar control in adults with type 2 diabetes.
• It can be used alone with diet and exercise, or with metformin, sulfonylureas, pioglitazone, insulin or other antidiabetic drugs, as the doctor decides.
• It can be taken with or without food.
• Teneligliptin and metformin is a widely used combination in India, and adding dapagliflozin extends it to three mechanisms.

Teneligliptin 20 mg price: The price varies by brand, pack size, city and pharmacy. For the current price of GLIDAPA TENMET 1000 or 500, check the MRP printed on the pack or ask your pharmacist. A triple fixed-dose tablet is often more economical than buying three separate medicines.

Dapagliflozin 10 mg Uses

Dapagliflozin 10 mg is the standard adult dose. It is used to improve blood sugar control in type 2 diabetes. As a standalone product, it is also approved to reduce the risk of hospitalisation for heart failure in adults with type 2 diabetes and cardiovascular disease or risk factors, to treat heart failure with reduced ejection fraction, and to slow the decline of kidney function in selected adults with chronic kidney disease.

Please note that the heart failure and kidney indications belong to the single-ingredient dapagliflozin product. In a fixed-dose combination such as GLIDAPA TENMET, the labelled indication is blood sugar control in type 2 diabetes. Your doctor decides whether the extra heart and kidney benefits are relevant to you.

Metformin Tablet Uses and Metformin Hydrochloride Uses

Metformin hydrochloride tablet uses include:

• Lowering blood sugar in type 2 diabetes, alone or with other antidiabetic medicines
• Reducing insulin resistance
• Helping prevent or delay type 2 diabetes in selected people with prediabetes, as advised by a doctor
• Being used by doctors in some cases in polycystic ovary syndrome (PCOS), which is an off-label use that only a doctor should decide

Metformin hydrochloride 500 mg (also seen as metformin hydrochloride tablets IP 500mg) is the usual starting strength, often increased gradually to reduce stomach upset. Metformin hydrochloride 1000 mg uses are the same, but this strength is generally used when a higher dose is needed and well tolerated. In an extended release tablet, the dose is often taken once daily with the evening meal, or as your doctor directs. Strengths in a fixed-dose tablet should match the metformin dose your doctor wants you to take, which is why both 500 and 1000 options exist.

Efficacy and Clinical Evidence

The evidence for this combination comes from trials of each ingredient and from studies of combinations and add-on use.

Metformin evidence: The UK Prospective Diabetes Study (UKPDS 34) showed that metformin reduced diabetes-related complications and all-cause mortality in overweight patients with newly diagnosed type 2 diabetes. It remains one of the most cited trials supporting metformin as first-line therapy.

Teneligliptin evidence: Phase 3 trials in Japan and Korea showed that teneligliptin 20 mg and 40 mg once daily significantly reduced HbA1c compared with placebo, both alone and as add-on to metformin, glimepiride and pioglitazone. Long-term Japanese studies showed the effect was maintained for up to 52 weeks. Indian studies have reported HbA1c and post-meal glucose reductions with good tolerability, including in patients with kidney impairment.

Dapagliflozin evidence: In randomised trials, dapagliflozin added to metformin lowered HbA1c, fasting glucose and body weight (Bailey et al., Lancet 2010). A 52-week comparison with glipizide added to metformin (Nauck et al., Diabetes Care 2011) showed similar HbA1c reductions but weight loss and far fewer hypoglycaemic episodes with dapagliflozin. DECLARE-TIMI 58 showed a lower rate of hospitalisation for heart failure or cardiovascular death. DAPA-HF and DAPA-CKD extended the evidence to heart failure and chronic kidney disease.

Combination evidence: Studies of SGLT2 inhibitor plus DPP-4 inhibitor combinations show additive HbA1c lowering without a major rise in hypoglycaemia. Trials of dapagliflozin added to a DPP-4 inhibitor, with or without metformin, reported additional HbA1c reduction and weight loss compared with placebo. Smaller Indian studies of teneligliptin with dapagliflozin and metformin report good glycaemic control and acceptable tolerability, although many are short or observational.

Key Benefits of GLIDAPA TENMET

• Triple-action glucose control: Kidneys, incretin pathway and liver/muscle are all targeted.
• Fewer tablets: One tablet replaces three, which supports adherence.
• Low hypoglycaemia risk: None of the three usually causes low blood sugar on its own, unless combined with insulin or a sulfonylurea.
• Weight-friendly: Dapagliflozin may give modest weight loss, while metformin and teneligliptin are generally weight-neutral.
• Possible mild blood pressure reduction: Seen with dapagliflozin.
• Extended release metformin: Better stomach tolerance and convenient dosing.
• Insulin-independent action: The dapagliflozin effect does not rely on beta-cell function.
• Two strengths: The 500 and 1000 options help doctors individualise the metformin dose.

Dosage and How to Take

Follow your doctor’s prescription exactly. General guidance:

• Take the tablet once daily, or as directed, with or just after a meal to reduce stomach upset.
• Swallow whole with water. Do not crush, chew or break extended release tablets.
• Stay well hydrated unless your doctor has restricted fluids.
• Keep the genital area clean and dry to reduce the chance of fungal infections.
• Take it at the same time each day.
• Do not change the dose or stop the medicine without medical advice.

Side Effects

Common: nausea, diarrhoea, abdominal discomfort, increased urination, genital fungal infections, urinary tract infections, headache, nasopharyngitis (cold-like symptoms), dizziness, thirst, metallic taste.

Less common but important:

• Lactic acidosis (rare, linked to metformin)
• Diabetic ketoacidosis, including a form with near-normal blood sugar (euglycaemic DKA)
• Dehydration or low blood pressure, especially in older adults or those on diuretics
• Reduced kidney function
• Pancreatitis (reported with DPP-4 inhibitors)
• Severe joint pain (reported with DPP-4 inhibitors)
• Low vitamin B12 with long-term metformin use
• Fournier’s gangrene, a very rare but serious genital infection

Seek urgent medical care for severe stomach pain, persistent vomiting, rapid breathing, unusual tiredness or muscle pain, severe joint pain, or pain, redness and swelling around the genitals with fever.

Precautions and Who Should Avoid It

• Do not use in type 1 diabetes or diabetic ketoacidosis.
• Do not use if you are allergic to any ingredient.
• Metformin is contraindicated in severe kidney impairment (eGFR below 30), and the glucose-lowering effect of dapagliflozin falls as kidney function falls. Your doctor will check eGFR before and during treatment.
• Avoid in serious liver disease, and use caution in heart or respiratory failure with low oxygen.
• Stop and consult your doctor before iodinated contrast scans, major surgery, prolonged fasting, or illness with vomiting or diarrhoea.
• Tell your doctor if you have had pancreatitis, recurrent genital or urinary infections, or low blood pressure, or if you take diuretics.
• Pregnancy and breastfeeding: generally not recommended. Speak with your doctor.
• If you also take insulin or a sulfonylurea, those doses may need reducing.
• Avoid heavy alcohol use, as it raises the risk of lactic acidosis.
• Doctors may check vitamin B12 periodically during long-term metformin use.

Storage

Store below 30°C in a cool, dry place, away from light and out of the reach of children. Follow the manufacturer’s instructions on the pack.

Frequently Asked Questions

1. What is GLIDAPA TENMET tablet used for?
It is used to control blood sugar in adults with type 2 diabetes. It contains dapagliflozin, teneligliptin and metformin hydrochloride extended release.

2. What is the difference between GLIDAPA TENMET 1000 and GLIDAPA TENMET 500?
Both contain dapagliflozin 10mg and teneligliptin 20mg. The 1000 has metformin 1000mg and the 500 has metformin 500mg. Your doctor selects the strength.

3. What are teneligliptin dapagliflozin and metformin tablet uses?
The combination improves blood sugar control in adults with type 2 diabetes when two of these medicines are not enough.

4. What are teneligliptin 20 mg uses?
Teneligliptin 20 mg is used once daily to improve blood sugar control in adults with type 2 diabetes, alone or with other antidiabetic medicines.

5. What is the teneligliptin 20 mg price?
The price varies by brand, pack and pharmacy. Check the MRP on the pack or ask your pharmacist for the current price.

6. What does dapagliflozin do in the body?
It blocks SGLT2 in the kidneys so that excess glucose leaves the body in the urine, which lowers blood sugar.

7. What are dapagliflozin 10 mg uses?
Mainly type 2 diabetes. The standalone drug is also used in selected patients with heart failure or chronic kidney disease, as decided by a doctor.

8. What is dapagliflozin propanediol monohydrate?
It is the stable crystalline form of dapagliflozin used in tablets. It works the same way as dapagliflozin in the body.

9. What are metformin tablet uses?
Metformin lowers blood sugar in type 2 diabetes by reducing liver glucose output and improving insulin sensitivity. Doctors sometimes use it in prediabetes and PCOS in specific cases.

10. What are metformin hydrochloride 1000 mg uses?
It is used for type 2 diabetes in patients who need a higher metformin dose and tolerate it well, as decided by a doctor.

11. What is the difference between extended release metformin and normal metformin?
Extended release tablets release the drug slowly, which usually causes fewer stomach side effects and allows less frequent dosing.

12. Can this tablet cause low blood sugar?
The risk is low on its own, but it can rise if combined with insulin or a sulfonylurea such as glimepiride.

13. Can GLIDAPA TENMET cause weight loss?
Dapagliflozin may cause modest weight loss, but this tablet is not a weight-loss medicine and should not be used for that purpose.

14. When should I take this tablet?
Usually with or just after a meal, as your doctor directs.

15. What are the common side effects of teneligliptin, metformin and dapagliflozin?
Nausea, diarrhoea, increased urination, genital or urinary infections, headache and dizziness are among the common ones.

Conclusion

GLIDAPA TENMET 1000 and GLIDAPA TENMET 500 bring together dapagliflozin 10mg, teneligliptin 20mg and metformin hydrochloride extended release in one tablet for adults with type 2 diabetes who need triple therapy. The combination targets three complementary pathways, has a low risk of hypoglycaemia, may support modest weight and blood pressure benefits, and reduces pill burden. It still needs proper patient selection, regular monitoring of HbA1c, kidney function and vitamin B12, and awareness of dehydration, genital infection, lactic acidosis and ketoacidosis risks. This is a prescription-only medicine, and the strength must be chosen by your doctor. This article is for information only and is not a substitute for medical advice.

For Further More Information:  

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +918824175417, +919982524671

Buy Now